What Is Vitiligo
Vitiligo is a long-term skin condition in which patches of skin lose their pigment, resulting in lighter or white areas that can appear on the face, hands, arms, feet, and other parts of the body. The condition occurs when melanocytes, the cells responsible for skin color, are destroyed or stop functioning, and it affects people of all skin types, though it is more visible on darker skin tones. According to the National Institutes of Health, vitiligo affects roughly 1 to 2 percent of the global population, making it one of the most common depigmentation disorders worldwide National Institutes of Health data on prevalence. The condition is not contagious, life-threatening, or linked to a single cause, but it is widely recognized as an autoimmune disorder in which the body's immune system mistakenly attacks its own melanocytes.
In medical English, vitiligo is classified into several types based on how the white patches spread, including generalized, segmental, and localized forms, with generalized vitiligo being the most common pattern where patches appear symmetrically on both sides of the body. Researchers continue to study the exact triggers, but leading institutions point to a combination of genetic susceptibility, autoimmune activity, oxidative stress, and environmental factors such as sunburn or chemical exposure World Health Organization fact sheet on vitiligo. The condition can begin at any age, though more than half of cases start before the age of 20, and it sometimes coexists with other autoimmune diseases such as thyroid disorders, type 1 diabetes, or alopecia areata.
Causes, Symptoms, and Diagnosis
The primary symptom of vitiligo is the appearance of flat, smooth, white patches on the skin that may start small and gradually enlarge, often first showing up around the eyes, mouth, hands, or joints. In segmental vitiligo, the patches tend to stay on one side or one area of the body and may spread quickly for a year or two before stabilizing, while non-segmental vitiligo can be more unpredictable and widespread. Doctors usually diagnose vitiligo through a physical exam, Wood's lamp examination, and sometimes skin biopsy or blood tests to check for associated autoimmune conditions American Academy of Dermatology overview.
Although the exact cause remains unclear, studies highlight that certain genes related to immune function and melanocyte protection are more common in people with vitiligo, and emotional or physical stress can sometimes trigger new patches. The condition does not directly cause severe health problems, but the loss of skin pigment can lead to sun sensitivity in the affected areas, meaning patients need to use sunscreen and protect their skin from excessive UV exposure. Eye inflammation, hearing loss, and changes in tear production are less common associated issues that some patients experience, and ongoing research aims to better understand the biological pathways that lead to pigment loss.
Treatment Options and Current Research
There is currently no single cure for vitiligo, but treatments aim to restore color, slow the spread of patches, or improve the appearance of the skin, and the choice depends on the type, extent, and location of the vitiligo as well as the patient's age and preferences. Common approaches include topical corticosteroids and calcineurin inhibitors, phototherapy using narrowband UVB or excimer lasers, and in some cases oral medications or surgical options such as skin grafting or melanocyte transplantation FDA approval of afamelanotide for vitiligo. Recent